Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Lee, Seung Joon ^a   Langhans, Sigrid A ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHASE PROMOTING COMPLEX; ANAPHASE PROMOTING COMPLEX 3; CURCUMIN; LIGASE; PROTEIN CDC27; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG PROTEIN BINDING; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDULLOBLASTOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CEREBELLAR NEOPLASMS; CURCUMIN; HUMANS; MEDULLOBLASTOMA; PHOSPHORYLATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84862820430     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-44     Document Type: Article

References (38)

1. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 2008, 267(1):133-164. 10.1016/j.canlet.2008.03.025, 18462866.
2. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008, 269(2):199-225. 10.1016/j.canlet.2008.03.009, 18479807.
3. Lee SJ, Krauthauser C, Maduskuie V, Fawcett PT, Olson JM, Rajasekaran SA. Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo. BMC Cancer 2011, 11:144. PMCID: 3090367, 10.1186/1471-2407-11-144, 3090367, 21501498.
4. Bangaru ML, Chen S, Woodliff J, Kansra S. Curcumin (diferuloylmethane) induces apoptosis and blocks migration of human medulloblastoma cells. Anticancer Res 2010, 30(2):499-504.
5. Elamin MH, Shinwari Z, Hendrayani SF, Al-Hindi H, Al-Shail E, Khafaga Y, et al. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Mol Carcinog 2010, 49(3):302-314.
6. Ravindran J, Prasad S, Aggarwal BB, . Curcumin and Cancer Cells How Many Ways Can Curry Kill Tumor Cells Selectively?. AAPS J 2009, 11(3):495-510. 10.1208/s12248-009-9128-x, 2758121, 19590964, Curcumin and Cancer Cells.
7. Sa G, Das T. Anti cancer effects of curcumin: cycle of life and death. Cell Division 2008, 3(1):14. 10.1186/1747-1028-3-14, 2572158, 18834508.
8. Karunagaran D, Joseph J, Kumar TR. Cell growth regulation. Adv Exp Med Biol 2007, 595:245-268. 10.1007/978-0-387-46401-5_11, 17569215.
9. Rieder CL, Maiato H. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 2004, 7(5):637-651. 10.1016/j.devcel.2004.09.002, 15525526.
10. Weaver BA, Cleveland DW. Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell 2005, 8(1):7-12. 10.1016/j.ccr.2005.06.011, 16023594.
11. Peters JM. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat Rev Mol Cell Biol 2006, 7(9):644-656. 10.1038/nrm1988, 16896351.
12. van Leuken R, Clijsters L, Wolthuis R. To cell cycle, swing the APC/C. Biochim Biophys Acta 2008, 1786(1):49-59.
13. Bernard K, Wang W, Narlawar R, Schmidt B, Kirk KL. Curcumin cross-links cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides and potentiates CFTR channel activity by distinct mechanisms. J Biol Chem 2009, 284(45):30754-30765. 10.1074/jbc.M109.056010, 2781474, 19740743.
14. Rajasekaran SA, Christiansen JJ, Schmid I, Oshima E, Ryazantsev S, Sakamoto K, et al. Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability. Mol Cancer Ther 2008, 7(7):2142-2151. 10.1158/1535-7163.MCT-08-0005, 2548318, 18645024.
15. Conboy L, Foley AG, O'Boyle NM, Lawlor M, Gallagher HC, Murphy KJ, et al. Curcumin-induced degradation of PKC delta is associated with enhanced dentate NCAM PSA expression and spatial learning in adult and aged Wistar rats. Biochem Pharmacol 2009, 77(7):1254-1265. 10.1016/j.bcp.2008.12.011, 19161989.
16. Peters JM, King RW, Hoog C, Kirschner MW. Identification of BIME as a subunit of the anaphase-promoting complex. Science 1996, 274(5290):1199-1201. 10.1126/science.274.5290.1199, 8895470.
17. Sudakin V, Chan GK, Yen TJ. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 2001, 154(5):925-936. PMCID: 2196190, 10.1083/jcb.200102093, 2196190, 11535616.
18. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 2007, 595:1-75. 10.1007/978-0-387-46401-5_1, 17569205.
19. Matyskiela ME, Morgan DO. Analysis of activator-binding sites on the APC/C supports a cooperative substrate-binding mechanism. Mol Cell 2009, 34(1):68-80. 10.1016/j.molcel.2009.02.027, 2754851, 19362536.
20. Thornton BR, Ng TM, Matyskiela ME, Carroll CW, Morgan DO, Toczyski DP. An architectural map of the anaphase-promoting complex. Genes Dev 2006, 20(4):449-460. 10.1101/gad.1396906, 1369047, 16481473.
21. Nasmyth K. Segregating sister genomes: the molecular biology of chromosome separation. Science 2002, 297(5581):559-565. 10.1126/science.1074757, 12142526.
22. Huang JY, Morley G, Li D, Whitaker M. Cdk1 phosphorylation sites on Cdc27 are required for correct chromosomal localisation and APC/C function in syncytial Drosophila embryos. J Cell Sci 2007, 120(Pt 12):1990-1997. PMCID: 2082081, 2082081, 17519285.
23. Zhang L, Fujita T, Wu G, Xiao X, Wan Y. Phosphorylation of the anaphase-promoting complex/Cdc27 is involved in TGF-beta signaling. J Biol Chem 2011, 286(12):10041-10050. 10.1074/jbc.M110.205518, 21209074.
24. King RW, Peters JM, Tugendreich S, Rolfe M, Hieter P, Kirschner MW. A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 1995, 81(2):279-288. 10.1016/0092-8674(95)90338-0, 7736580.
25. Kraft C, Herzog F, Gieffers C, Mechtler K, Hagting A, Pines J, et al. Mitotic regulation of the human anaphase-promoting complex by phosphorylation. EMBO J 2003, 22(24):6598-6609. 10.1093/emboj/cdg627, 291822, 14657031.
26. Yu H. Cdc20: a WD40 activator for a cell cycle degradation machine. Mol Cell 2007, 27(1):3-16. 10.1016/j.molcel.2007.06.009, 17612486.
27. Kimata Y, Baxter JE, Fry AM, Yamano H. A role for the Fizzy/Cdc20 family of proteins in activation of the APC/C distinct from substrate recruitment. Mol Cell 2008, 32(4):576-583. 10.1016/j.molcel.2008.09.023, 19026787.
28. Banerjee M, Singh P, Panda D. Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells. FEBS J 2010, 277(16):3437-3448. 10.1111/j.1742-4658.2010.07750.x, 20646066.
29. Gupta KK, Bharne SS, Rathinasamy K, Naik NR, Panda D. Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding. FEBS J 2006, 273(23):5320-5332. 10.1111/j.1742-4658.2006.05525.x, 17069615.
30. Perez EA. Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther 2009, 8(8):2086-2095. 10.1158/1535-7163.MCT-09-0366, 19671735.
31. Westermann S, Weber K. Post-translational modifications regulate microtubule function. Nat Rev Mol Cell Biol 2003, 4(12):938-947. 10.1038/nrm1260, 14685172.
32. Kim AH, Puram SV, Bilimoria PM, Ikeuchi Y, Keough S, Wong M, et al. A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons. Cell 2009, 136(2):322-336. 10.1016/j.cell.2008.11.050, 2707082, 19167333.
33. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, et al. HDAC6 is a microtubule-associated deacetylase. Nature 2002, 417(6887):455-458. 10.1038/417455a, 12024216.
34. Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer 2010, 10(3):194-204. 10.1038/nrc2803, 20147901.
35. Huang HC, Shi J, Orth JD, Mitchison TJ. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 2009, 16(4):347-358. 10.1016/j.ccr.2009.08.020, 2758291, 19800579.
36. Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC. Advanced Drug-Delivery Systems of Curcumin for Cancer Chemoprevention. Cancer Prev Res (Phila) 2011, 4(8):1158-1171.
37. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007, 4(6):807-818. 10.1021/mp700113r, 17999464.
38. Altunbas A, Lee SJ, Rajasekaran SA, Schneider JP, Pochan DJ. Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials 2011, 32(25):5906-5914. 10.1016/j.biomaterials.2011.04.069, 3119512, 21601921.